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journal.publications.chestneThere exists a high prevalence of OSA in the general population, a great proportion of which
remains undiagnosed. The snoring, tiredness, observed apnea, high BP, BMI, age, neck
circumference, and male gender (STOP-Bang) questionnaire was speciﬁcally developed to
meet the need for a reliable, concise, and easy-to-use screening tool. It consists of eight
dichotomous (yes/no) items related to the clinical features of sleep apnea. The total score
ranges from 0 to 8. Patients can be classiﬁed for OSA risk based on their respective scores. The
sensitivity of STOP-Bang score $ 3 to detect moderate to severe OSA (apnea-hypopnea index
[AHI] > 15) and severe OSA (AHI > 30) is 93% and 100%, respectively. Corresponding
negative predictive values are 90% and 100%. As the STOP-Bang score increases from 0 to
2 up to 7 to 8, the probability of moderate to severe OSA increases from 18% to 60%, and the
probability of severe OSA rises from 4% to 38%. Patients with a STOP-Bang score of 0 to 2 can
be classiﬁed as low risk for moderate to severe OSA whereas those with a score of 5 to 8 can be
classiﬁed as high risk for moderate to severe OSA. In patients whose STOP-Bang scores are in
the midrange (3 or 4), further criteria are required for classiﬁcation. For example, a STOP-Bang
score of$ 2 plus a BMI > 35 kg/m2 would classify that patient as having a high risk for moderate
to severe OSA. In this way, patients can be stratiﬁed for OSA risk according to their STOP-Bang
scores. CHEST 2016; 149(3):631-638
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hypopnea events occur during sleep, most patients with
OSA may not be aware that they have the condition. It
has been estimated that up to 80% of individuals with
moderate to severe OSA may remain undiagnosed and,
more alarmingly, untreated.5
The prevalence of OSA speciﬁcally found in surgical
patients differs among various populations. The
prevalence rate is approximately 70% in patients
undergoing bariatric surgery6 and 8.4% of orthopedic
patients,7 and 7.2% among patients undergoing a variety
of surgeries.8 Since 60% of surgical patients with
moderate to severe OSA were not recognized or
diagnosed preoperatively,9,10 the point estimates from
these studies may actually be an underestimation.
Because of the potentially serious adverse consequences
associated with untreated OSA in the general and
surgical population, prompt diagnosis and treatment
of unrecognized OSA is critical. The reference standard
for diagnosis of OSA is an overnight polysomnogram
(PSG). However, the procedure is time-consuming,
labor-intensive, and costly. Growing awareness of sleep
apnea has extended the already long waiting lists in many
sleep laboratories.11 As a result, patients with OSA are
currently left waiting a mean of 11.6 months before being
able to initiate medical therapy (CPAP) and 16.2 months
before being able to initiate surgical therapy in Ontario,
Canada.12 Moreover, PSG requires the expertise of sleep
medicine specialists, who may not be readily available at
many hospitals and medical centers. All of these factors
exacerbate delays that can prevent prompt diagnosis
and treatment of OSA, which further emphasizes the
vital need for a simple, practical, and reliable method of
identifying and triaging patients at high risk of OSA. In
an effort to deal with this issue, a number of screening
tests were developed to identify high-risk patients.8,13-19
Many are lengthy and complicated, and require upper
airway assessment, which makes them inconvenient to
use and vulnerable to variability among clinicians
performing the upper airway assessment.
The STOP and STOP-Bang Questionnaire
The snoring, tiredness, observed apnea, high BP
(STOP) and snoring, tiredness, observed apnea, high
BP-BMI, age, neck circumference and gender (STOP-
Bang) questionnaires (e-Appendix 1) were developed in
response to the need for a concise, user-friendly OSA
screening tool in preoperative clinics.20 The STOP
questionnaire includes four questions related to
snoring, tiredness, observed apnea and high blood
pressure, and shows a moderately high level of632 Commentarysensitivity (65.6%) and speciﬁcity (60%) in detecting
OSA (AHI > 5) in surgical patients.20 For moderate
to severe OSA (AHI > 15), the sensitivity and
speciﬁcity of the STOP questionnaire are 74% and
53%, respectively. For severe OSA (AHI > 30),
sensitivity is 80% and speciﬁcity is 49%.20
The STOP-Bang questionnaire includes the four questions
used in the STOP questionnaire plus four additional
demographic queries,20 for a total of eight dichotomous
(yes/no) questions related to the clinical features of sleep
apnea (snoring, tiredness, observed apnea, high blood
pressure, BMI, age, neck circumference and male gender).
For each question, answering “yes” scores 1, a “no”
response scores 0, and the total score ranges from 0 to 8.
The components of STOP questionnaire were selected
based on the factor analysis of 14 candidate questions
designed to reﬂect snoring, daytime tiredness, observed
breathing cessation, and high BP.20 The “Bang” items were
chosen based on univariate analysis of item predictive
performance. The diagnostic OR to detect OSA (AHI
> 5 events/h) was 1.949 (95% CI, 0.792-4.798) for BMI
> 35 kg/m2; 4.024 (95%CI, 2.023-8.003) for age> 50 years;
4.943 (95% CI, 1.963-12.446) for neck circumference
> 40 cm, and 2.767 (95% CI, 1.419-5.396) for male gender
(F. C., unpublished data, February 2014).
The questionnaire can be completed quickly and easily
(usually within 1-2 min), and overall response rates are
typically high (90%-100%).20 The questionnaire has
demonstrated a high sensitivity using a cutoff score of
$ 3: 84% in detecting any sleep apnea (AHI> 5 events/h),
93% in detecting moderate to severe sleep apnea (AHI
> 15 events/h), and 100% in detecting severe sleep apnea
(AHI> 30 events/h).20 Corresponding speciﬁcities were
56.4%, 43%, and 37%.20 If patients score 0 to 2 on the
STOP-Bang questionnaire, they are considered to be at low
risk of OSA, and the possibility of those patients having
moderate to severe sleep apnea can be conﬁdently ruled out.
Because of its ease of use, efﬁciency, and high sensitivity,
the STOP-Bang questionnaire has been widely adopted
and validated in various populations and among patients
with assorted medical conditions. It has been applied in
sleep21-30 and medical clinics,31 surgical patients,32,33 the
general population,34,35 pregnant patients,36 individuals
with mental illness,37 highway bus drivers,38-40 and
patients with renal failure.41
Association Between STOP-Bang Scores and
Predictive Probability of OSA
Although the high sensitivity of the STOP-Bang
questionnaire makes it useful as an OSA screening tool,[ 1 4 9 # 3 CHES T MA R C H 2 0 1 6 ]
it is possible that the modest speciﬁcity (43% to detect
moderate to severe sleep apnea) will yield a high false-
positive rate.20 This, in turn, could result in unnecessary
referral to sleep clinics for polysomnography, as well as
increase the cost of care for surgical patients owing to
additional perioperative monitoring. To address these
issues effectively and help curb unnecessary treatment
or expenses, we further investigated the relationship
between STOP-Bang scores and the predicted
probability of OSA speciﬁcally in surgical patients.33 We
discovered that as the STOP-Bang scores increased from
0 to 2 up to 7 to 8, the probability of moderate to severe
OSA increased from 18% to 60% and the probability of
severe OSA rose from 4% to 38% (Table 1).33
In total, the relationship between the various STOP-
Bang scores and the predicted probability of OSA has
been investigated through four studies: two conducted
with patients referred to sleep clinics21,42 and two
with surgical patients.32,33 Figure 1 features the results of
pooled data from these studies. In both sleep clinic
(Fig 1A, 1B) (N¼ 1,852) and surgical patients (Fig 1C, 1D)
(N ¼ 957), the probability of moderate OSA (AHI,
15-30) (Fig 1A, 1C) stayed almost the same in patients
with STOP-Bang scores of 3, 4, and 5, and then
gradually decreased at STOP-Bang scores of 6 and 7/8.
In contrast, the probability of severe OSA (AHI > 30)
(Fig 1B, 1D) steadily increased as the STOP-Bang score
increased from 3 to 7 or 8. The data indicate that as
the STOP-Bang score increases, the probability of
severe OSA increases but the probability of moderate
OSA does not.Alternative Models for Scoring the STOP-Bang
Questionnaire
For ease of use, all items on the STOP-Bang
questionnaire are treated equally for scoring purposes,
using a count of 0 or 1. The items on the questionnaireTABLE 1 ] STOP-Bang Scores and Predicted Probabilities fo
in a Surgical Population
STOP-Bang Score Any OSA (AHI > 5) Mod
0-2 0.46 (0.39-0.53)
3 0.72 (0.65-0.78)
4 0.73 (0.66-0.79)
5 0.77 (0.69-0.84)
6 0.79 (0.68-0.87)
7 and 8 0.86 (0.72-0.93)
Data are given as probability (95% CI). AHI ¼ apnea-hypopnea index; STO
circumference, and male gender. (Adapted with permission Chung et al.33)
journal.publications.chestnet.orgdo not share an equal predictive weight for OSA.14,20
In the “Bang” components, BMI > 35 kg/m2, neck
circumference > 40 cm, and male gender are more
predictive than being of aged > 50 years.43 Whereas
previous studies showed that the prevalence of sleep
apnea tends to increase with age, the severity of sleep
apnea—as indicated by both the number of events and
the minimum oxygen saturation—actually decreases
with age.44
The predictive performance of speciﬁc combinations
of items has also been explored.43 Compared with the
speciﬁcity of 31% for detecting moderate to severe OSA
using a combination of any three positive items on
the STOP-Bang questionnaire, the following three
combinations signiﬁcantly improve the speciﬁcity to
detect any OSA (AHI > 5), moderate to severe OSA
(AHI > 15), and severe OSA (AHI > 30) at the expense
of sensitivity: (1) STOP score $ 2 plus BMI > 35 kg/m2;
(2) STOP score $ 2 plus neck circumference > 40 cm
(16 in); and (3) STOP score $ 2 plus male gender.43 The
speciﬁcity to detect moderate to severe OSA increases
as follows based on those different combinations: to
85% for the combination of a STOP score $ 2 plus BMI
> 35 kg/m2; to 79% for the combination of a STOP
score $ 2 plus neck circumference > 40 cm (16 in); and
to 77% for the combination of a STOP score $ 2 plus
male. These valuable data can assist in accurately
identifying more patients with moderate to severe OSA
(Table 2).The STOP-Bang Questionnaire and Serum
Bicarbonate
Chronic daytime hypercapnia (PaCO2 $ 45 mm Hg)
is found in 10% to 38% of patients with OSA,45 and
as the severity of OSA increases, the risk of chronic
daytime hypercapnia may also increase.46 Serum
bicarbonate (HCO3
-) may increase in moderate to severer Any OSA, Moderate-to-Severe OSA, and Severe OSA
erate/Severe OSA (AHI > 15) Severe OSA (AHI > 30)
0.18 (0.13-0.24) 0.04 (0.02-0.08)
0.36 (0.29-0.43) 0.13 (0.09-0.19)
0.42 (0.34-0.49) 0.18 (0.13-0.25)
0.50 (0.42-0.59) 0.30 (0.23-0.39)
0.57 (0.45-0.69) 0.32 (0.22-0.44)
0.60 (0.44-0.73) 0.38 (0.29-0.53)
P-Bang ¼ snoring, tiredness, observed apnea, high BP, BMI, age, neck
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Figure 1 – Relationship between SBQ score and the probability of OSA. A, SBQ score and probability of moderate OSA (apnea-hypopnea index [AHI]
> 15-30) in sleep clinic patients. B, SBQ score and probability of severe OSA (AHI > 30) in sleep clinic patients. C, SBQ score and probability of
moderate OSA (AHI > 15-30) in surgical patients. D, SBQ score and probability of severe OSA (AHI > 30) in surgical patients. (A) and (B) are
based on the meta-analysis of two studies in sleep clinics.21,43 (C) and (D) are based on the meta-analysis of two studies in surgical patients.32,33
SBQ ¼ STOP-Bang questionnaire; STOP-Bang ¼ snoring, tiredness, observed apnea, high BP, BMI, age, neck circumference, and male gender.
TABLE 2 ] Predictive Performance of Combination of Two Items From STOP and One From Bang for Identifying
Patients With Moderate to Severe Obstructive Sleep Apnea (Apnea-Hypopnea Index > 15)
Cutoff Sensitivity Speciﬁcity PPV NPV
STOP-Bang $ 3 87.3 (81.8-91.6) 30.7 (25.7-36.1) 43.8 (38.8-48.8) 79.7 (71.5-86.4)
STOP $ 2 þ Bang $ 1 71.6 (64.7-77.8) 46.1 (40.5-51.7) 45.0 (39.5-50.7) 72.4 (65.7-78.4)
STOP $ 2 þ BMI > 35 kg/m2 20.8 (15.4-27.2) 85.0 (80.6-88.7) 46.1 (35.4-57.0) 63.5 (58.7-68.0)
STOP $ 2 þ Neck > 40 cm 33.5 (27.0-40.6) 79.0 (74.1-83.3) 49.6 (40.8-58.4) 65.8 (60.8-70.5)
STOP $ 2 þ male gender 40.1 (33.2-47.3) 76.8 (71.8-81.3) 51.6 (43.4-59.8) 67.5 (62.4-72.3)
STOP $ 2 þ age > 50 y 59.4 (52.2-66.3) 56.1 (50.5-61.6) 45.5 (39.3-51.8) 69.1 (63.1-74.7)
Data are presented as average (95% CI). Bang ¼ BMI, age, neck circumference, and male gender; NPV ¼ negative predictive value; PPV ¼ positive
predictive value; STOP ¼ snoring, tiredness, observed apnea, and high BP. (Adapted with permission Chung et al.43)
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OSA without meeting criteria of overt chronic daytime
hypercapnia, as documented in obesity hypoventilation
syndrome.46 Obesity hypoventilation syndrome is
deﬁned by daytime hypercapnia and hypoxemia (PaCO2
> 45 mm Hg and PaO2 < 70 mm Hg) in an obese
patient (BMI > 30 kg/m2) who has sleep-disordered
breathing and which occurs in the absence of any other
cause of hypoventilation.45
Since nocturnal intermittent hypercapnia resulting from
to obstructive apnea or hypopnea may lead to renal
HCO3
– retention to compensate for acute respiratory
acidosis,47 it may subsequently result in elevated serum
HCO3
–. Our ﬁndings indicate that serum HCO3
– is
signiﬁcantly correlated to AHI,48 and the addition of
serum HCO3
– $ 28 mmol/L to a STOP-Bang score $ 3
improves the speciﬁcity to predict moderate to severe
OSA but decreases its sensitivity.48 Under that condition
(a STOP-Bang score of $ 3 plus HCO3
– $ 28 mmol/L),
the speciﬁcity for detecting moderate to severe OSA
increases from 30% to 82%, and from 28% to 80% for
detecting severe OSA.48Two-Step Strategy for Using STOP-Bang
Questionnaire
Based on these data,33,43,48 we propose a two-step
algorithm (Fig 2 ) to use the STOP-Bang questionnaire
to identify patients effectively with a high probability of
moderate to severe sleep apnea. As shown in Figure 2,
the ﬁrst step is to check the STOP-Bang score. If a
patient scores 0 to 2 on the STOP-Bang questionnaire,
he or she is unlikely to have moderate to severe OSA.Patients for OSA
Screening
STOP-Bang 3-4
(Intermediate Risk)
STOP-Bang 0-2
(Low Risk)
Other
(Intermediate Risk)
STOP ≥ 2 + Male
STOP ≥ 2 + BMI > 35
STOP ≥ 2 + Neck > 40 cm
(High Risk)
STOP-Bang ≥ 5
(High Risk)
Step Two
Step One
Figure 2 – STOP-Bang algorithm with a two-step scoring strategy. See
Figure 1 legend for expansion of abbreviation.
journal.publications.chestnet.orgConversely, a patient with a STOP-Bang score of 5 to 8
has a high probability of having moderate to severe OSA
(Table 1).33 The second step is for patients falling in the
middle: those with STOP-Bang scores of 3 or 4. These
patients can be further classiﬁed as having a higher risk
for moderate to severe OSA if one of the following
conditions is met: (1) the combination of a STOP score
of $ 2 plus BMI > 35 kg/m2; (2) a STOP score of
$ 2 plus male gender; (3) a STOP score of$ 2 plus neck
circumference > 40 cm (16 in); or (4) a STOP-Bang
score of $ 3 plus serum HCO3
– $ 28 mmol/L. This
two-step algorithm needs to be further validated
prospectively.
STOP-Bang Questionnaire in the General
Population and in Bus Drivers
Studies in primary care patients demonstrate that the
STOP-Bang questionnaire has predictive performance
similar to that seen in surgical and sleep clinic
patients.34,35 Silva et al35 evaluated the STOP-Bang
questionnaire in 4,770 participants in the Sleep Heart
Health Study. The prevalence of moderate to severe OSA
(respiratory disturbance index [RDI] $ 15 events/h) and
severe OSA (RDI $ 30 events/h) in this population was
13% and 7%, respectively. The sensitivity of a STOP-
Bang score $ 3 was 89% to detect moderate to severe
OSA (RDI$ 15 events/h) and 93% to detect severe OSA
(RDI $ 30 events/h). Speciﬁcities were 30% and 29%,
respectively. Positive predictive values (PPV) were lower:
16% and 9%, respectively. Negative predictive values
(NPV) were higher: 95% and 98%, respectively.35 The
relatively low PPV and high NPV were probably related
to the relatively low OSA prevalence in the study
population. In another study of 178 patients with
60% with OSA (AHI $ 5 events/h), the sensitivity of the
STOP-Bang questionnaire to detect OSA (AHI $ 5
events/h) was 96% whereas the speciﬁcity was 24%, PPV
was 66%, and NPV was 81%.34 Further research is
needed to investigate the association between STOP-
Bang scores and OSA probability in the general
population.
The STOP-Bang questionnaire has also been evaluated
for its ability to detect moderate to severe OSA in
highway bus drivers.38 The prevalence of moderate
to severe OSA among the highway bus drivers was
54%. Compared with other questionnaires (Berlin,
STOP, and OSA50), the STOP-Bang questionnaire had
the highest sensitivity and NPV and was more helpful
as a screening test to identify drivers at risk for OSA.38
The sensitivity and speciﬁcity of a STOP-Bang score635
$ 3 to detect moderate to severe OSA were 87% and
49%, respectively. The PPV and NPV was 66% and
76%, respectively.38
STOP-Bang Questionnaire in Obese Patients
The prevalence of OSA is high in the obese population.
In morbidly obese surgical patients (BMI $ 35 kg/m2),
84% had OSA (AHI > 5 events/h), 47% had moderate to
severe OSA (AHI > 15 events/h), and 27% had severe
OSA (AHI > 30 events/h).49 We evaluated the predictive
performance of the STOP-Bang questionnaire for OSA
in obese (BMI $ 30 kg/m2) and morbidly obese (BMI
$ 35 kg/m2) surgical patients.49 Although STOP-Bang
$ 3 is very sensitive (sensitivity range, 91%-100%) to
detect OSA in obese and morbidly obese patients, the
speciﬁcity is low (from 7%-28%), yielding high false-
positive rates. A STOP-Bang score cutoff of 4 provides a
better balance of sensitivity and speciﬁcity in the obese
population. In morbidly obese patients, a STOP-Bang
score $ 4 retained high sensitivity across the entire
spectrum of OSA severity, with a sensitivity of 90% for
detecting severe OSA,49 whereas a STOP-Bang score
$ 6 demonstrated a speciﬁcity of 81% for detecting
severe OSA.49
OSA Screening: Beneﬁts and Challenges
The high prevalence of undiagnosed OSA requires a
reliable, efﬁcient, and easily used screening tool. The
STOP-Bang questionnaire has been widely adopted to
fulﬁll this need. As the STOP-Bang score increases, the
probability of severe OSA rises. Using the STOP-Bang
questionnaire, sleep clinicians can quickly and reliably
identify those at risk of severe OSA and prioritize
patients for polysomnography or out-of-center sleep
testing. Similarly, surgical patients can be stratiﬁed for
OSA severity according to their STOP-Bang scores.
Several studies show that screening OSA with STOP-
Bang questionnaire identiﬁes patients with an increased
incidence of postoperative complications.50-52 Data from
a prospective study of 3,452 patients show that patients
identiﬁed as being at high risk of OSA by the STOP-
Bang questionnaire had a higher rate of postoperative
complications (9% vs 2% in patients with a low risk of
OSA), difﬁcult intubation (20% vs 9%), and difﬁcult
mask ventilation (23% vs 7%).51 The STOP-Bang score
was positively associated with postoperative critical care
admission.52 A prospective cohort study showed that
untreated OSA was independently associated with
more cardiopulmonary complications, particularly
unplanned reintubations and myocardial infarction.53636 CommentaryIn another retrospective study,54 a diagnosis of OSA
and prescription of CPAP therapy were associated
with a reduction in postoperative cardiovascular
complications. In a randomized controlled trial,
perioperative auto-titrating positive airway pressure
has been shown to prevent postoperative worsening
of OSA and desaturation in patients newly diagnosed
with OSA.55 However, the randomized controlled
trials did not show that the incidence of postoperative
complications was reduced by perioperative auto-
titrating positive airway pressure treatment,55,56
probably because of the small sample size (177 in the
study of Liao et al55 and 86 in the study of O’Gorman
et al56) and poor compliance with CPAP in these
studies.32,55-57 Further research is needed to identify
barriers to CPAP compliance in the perioperative setting.
Currently no data are available to evaluate the impact
of preoperative OSA screening and corresponding
perioperative care measures on perioperative outcomes.
We need to investigate prospectively whether a
perioperative pathway incorporating preoperative
OSA screening, perioperative OSA precautions, and
postoperative treatment of OSA improves perioperative
outcomes in patients with OSA.
OSA is independently associated with a higher rate of
long-term cardiovascular events after coronary artery
bypass.58 Effective OSA screening in a preoperative
clinic, followed by the initiation of CPAP treatment,
may yield long-term health beneﬁts.59
Limitations
When using the STOP-Bang questionnaire, several
key points should be taken into account. Although
the STOP-Bang questionnaire has been validated in
different populations, a selection bias might be present in
some of the validation studies. For example, most patients
in sleep clinics were referred because they were already
suspected of having sleep-related issues. In studies
targeting surgical patients, a self-selection bias from
patients themselves may have occurred in that patients
with preexisting sleep symptomsmight bemore willing to
consent to an overnight PSG.Generally speaking, younger
patients were more likely to decline the studies.20 As a
result of these potential selection biases, the high
prevalence of OSA in the study populations may affect
interpretation of the predictive parameters by presenting
a seemingly inﬂated PPV. Although the STOP-Bang
questionnaire is validated in multiple populations, it was
less useful in identifying OSA patients in two distinct
groups: the veteran population60 and patients with renal[ 1 4 9 # 3 CHES T MA R C H 2 0 1 6 ]
failure.41 To ensure effective screening, validation of the
STOP-Bang questionnaire in the speciﬁc target
population is recommended. Since measurement tapes
may not be consistently available in the physician’s ofﬁce,
and because of potential issues with measurement
variability in neck circumference, these challenges may
affect accuracy of the STOP-Bang score.Conclusions
Studies have demonstrated that the STOP-Bang
questionnaire is a concise, effective, and reliable OSA
screening tool. It can facilitate efﬁcient allocation of
resources in both diagnosing and treating previously
unrecognized OSA. The probability of moderate to
severe OSA increases in direct proportion to the STOP-
Bang score, which makes the questionnaire an easily
used tool for identifying patients at high risk for OSA.
Patients with a STOP-Bang score of 0 to 2 can be
classiﬁed as being at low risk for moderate to severe
OSA. Those with a STOP-Bang score of 5 to 8 can be
classiﬁed as being at high risk for moderate to severe
OSA. In patients with a STOP-Bang score of 3 or 4,
the speciﬁc combinations of positive items should be
examined further to ensure proper classiﬁcation. If a
combination of a STOP score$ 2 plus (BMI > 35 kg/m2
or male gender or neck circumference > 40 cm) or a
STOP-Bang score $ 3 plus serum HCO3
– $ 28 mmol/L
is found, these patients can be further classiﬁed as being
at high risk of moderate to severe OSA.
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